Patient Guide: A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 109 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04657289
Status: ACTIVE_NOT_RECRUITING
Condition: Neovascular Age-related Macular Degeneration (nAMD)
Phase: PHASE3

Find a Study Location Near You

This study is available at 109 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Capital Federal,
  • Capital Federal,
  • Rosario,
  • • And 106 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily